• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇的处方前研究

Pre-formulation studies of resveratrol.

作者信息

Robinson Keila, Mock Charlotta, Liang Dong

机构信息

a Department of Pharmaceutical Sciences , Texas Southern University , Houston , TX , USA.

出版信息

Drug Dev Ind Pharm. 2015;41(9):1464-9. doi: 10.3109/03639045.2014.958753. Epub 2015 Jul 21.

DOI:10.3109/03639045.2014.958753
PMID:25224342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4427559/
Abstract

CONTEXT

Resveratrol, a natural compound found in grapes, has potential chemotherapy effects but very low oral bioavailability in humans.

OBJECTIVE

To evaluate the solubility, pH stability profile, plasma protein binding (PPB) and stability in plasma for resveratrol.

METHODS

Solubility of resveratrol was measured in 10 common solvents at 25 °C using HPLC. The solution state pH stability of resveratrol was assessed in various United States Pharmacopeia buffers ranging from pH 2 to 10 for 24 h at 37 °C. Samples were analyzed up to 24 h. Human PPB was determined using ultracentrifugation technique. Standard solutions of drug were spiked to blank human plasma to yield final concentrations of 5, 12.5 or 25 μg/mL for determination. Finally, stability of resveratrol in human and rat plasma was also assessed at 37 °C. Aliquots of blank plasma were spiked with a standard drug concentration to yield final plasma concentration of 50 μg/mL. Samples were analyzed for resveratrol concentration up to 96 h.

RESULTS

Resveratrol has wide solubility ranging from 0.05 mg/mL in water to 374 mg/mL in polyethylene glycol 400 (PEG-400). Resveratrol is relatively stable above pH 6 and has maximum degradation at pH 9. The mean PPB of resveratrol is 98.3%. Resveratrol degrades in human and rat plasma in a first-order process with mean half lives of 54 and 25 h, respectively.

CONCLUSION

Resveratrol is more soluble in alcohol and PEG-400 and stable in acidic pH. It binds highly to plasma proteins and degrades slower in human then rat plasma.

摘要

背景

白藜芦醇是一种存在于葡萄中的天然化合物,具有潜在的化疗作用,但在人体中的口服生物利用度非常低。

目的

评估白藜芦醇的溶解度、pH稳定性、血浆蛋白结合率(PPB)及在血浆中的稳定性。

方法

采用高效液相色谱法(HPLC)在25℃下测定白藜芦醇在10种常用溶剂中的溶解度。在37℃下,于pH值2至10的各种美国药典缓冲液中评估白藜芦醇的溶液状态pH稳定性,持续24小时。对样品进行长达24小时的分析。采用超速离心技术测定人血浆蛋白结合率。将药物标准溶液加入空白人血浆中,使其最终浓度分别为5、12.5或25μg/mL进行测定。最后,还在37℃下评估白藜芦醇在人和大鼠血浆中的稳定性。将空白血浆等分试样加入标准药物浓度,使其最终血浆浓度为50μg/mL。对样品进行长达96小时的白藜芦醇浓度分析。

结果

白藜芦醇具有广泛的溶解度,在水中为0.05mg/mL,在聚乙二醇400(PEG - 400)中为374mg/mL。白藜芦醇在pH值6以上相对稳定,在pH值9时降解最大。白藜芦醇的平均血浆蛋白结合率为98.3%。白藜芦醇在人和大鼠血浆中以一级过程降解,平均半衰期分别为54小时和25小时。

结论

白藜芦醇在乙醇和PEG - 400中更易溶解,在酸性pH条件下稳定。它与血浆蛋白高度结合,在人血浆中的降解速度比大鼠血浆慢。

相似文献

1
Pre-formulation studies of resveratrol.白藜芦醇的处方前研究
Drug Dev Ind Pharm. 2015;41(9):1464-9. doi: 10.3109/03639045.2014.958753. Epub 2015 Jul 21.
2
A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study.一种用于定量大鼠血浆中3,5,4'-三甲氧基反式芪(TMS)的快速高效液相色谱法及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2009 Feb 20;49(2):387-92. doi: 10.1016/j.jpba.2008.10.042. Epub 2008 Nov 5.
3
Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.用于增强白藜芦醇制剂和控制其递送的树枝状聚合物纳米技术。
Ann N Y Acad Sci. 2015 Aug;1348(1):134-40. doi: 10.1111/nyas.12816. Epub 2015 Jul 14.
4
Improved stability of trans-resveratrol in aqueous solutions by carboxymethylated (1,3/1,6)-β-D-glucan.通过羧甲基化(1,3/1,6)-β-D-葡聚糖提高反式白藜芦醇在水溶液中的稳定性。
J Agric Food Chem. 2014 Feb 19;62(7):1520-5. doi: 10.1021/jf404155e. Epub 2014 Feb 6.
5
Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature.反式白藜芦醇的稳定性和溶解度受pH值和温度的影响很大。
Eur J Pharm Biopharm. 2015 Jun;93:196-204. doi: 10.1016/j.ejpb.2015.04.002. Epub 2015 Apr 10.
6
Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.白藜芦醇三甲醚在Sprague-Dawley大鼠中的临床前药代动力学评估:水溶性、剂量递增、食物及重复给药对口服生物利用度的影响
J Pharm Sci. 2011 Oct;100(10):4491-500. doi: 10.1002/jps.22588. Epub 2011 Apr 24.
7
Preformulation studies of novel 5'-O-carbonates of lamivudine with biological activity: solubility and stability assays.
Drug Dev Ind Pharm. 2014 Sep;40(9):1246-52. doi: 10.3109/03639045.2013.814064. Epub 2013 Jul 15.
8
Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies.高效液相色谱法对大鼠血浆中顺式和反式白藜芦醇的立体特异性测定:在药代动力学研究中的应用
Biomed Chromatogr. 2007 Mar;21(3):257-65. doi: 10.1002/bmc.747.
9
Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology.利用树枝状聚合物纳米技术开发用于商业应用的局部白藜芦醇制剂。
Molecules. 2017 Jan 14;22(1):137. doi: 10.3390/molecules22010137.
10
[Resveratrol in Pharmaceutical Chemistry].[药物化学中的白藜芦醇]
Acta Pharm Hung. 2015;85(4):123-9.

引用本文的文献

1
In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer.白藜芦醇脂质体靶向肺癌中TLR4/NLRP3通路的体内机制
Sci Rep. 2025 Aug 28;15(1):31737. doi: 10.1038/s41598-025-14587-8.
2
Antioxidant Electrospun Poly(3-hydroxybutyrate--3-hydroxyvalerate) (PHBV) Films Loaded with Resveratrol Solubilized in Deep Eutectic Solvents.负载溶解于低共熔溶剂中的白藜芦醇的抗氧化电纺聚(3-羟基丁酸酯-3-羟基戊酸酯)(PHBV)薄膜
ACS Appl Polym Mater. 2025 Aug 7;7(16):10416-10429. doi: 10.1021/acsapm.5c01101. eCollection 2025 Aug 22.
3
Resveratrol Impairs Insulin Signaling in Hepatic Cells via Activation of PKC and PTP1B Pathways.

本文引用的文献

1
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.基于脂质纳米粒的新型白藜芦醇递药系统以提高其口服生物利用度。
Int J Nanomedicine. 2013;8:177-87. doi: 10.2147/IJN.S37840. Epub 2013 Jan 7.
2
Activation energy of light induced isomerization of resveratrol.白藜芦醇光诱导异构化的活化能。
J Fluoresc. 2011 Sep;21(5):1897-906. doi: 10.1007/s10895-011-0886-3. Epub 2011 Apr 15.
3
Transport, stability, and biological activity of resveratrol.白藜芦醇的运输、稳定性和生物活性。
白藜芦醇通过激活蛋白激酶C和蛋白酪氨酸磷酸酶1B信号通路损害肝细胞中的胰岛素信号。
Int J Mol Sci. 2025 Aug 1;26(15):7434. doi: 10.3390/ijms26157434.
4
Development and Evaluation of Trans-Resveratrol-Loaded Transfersomes: Role of Cholesterol in Formulation Design for Dermal Delivery.载有反式白藜芦醇的传递体的开发与评价:胆固醇在皮肤给药制剂设计中的作用。
Nanotechnol Sci Appl. 2025 Jul 31;18:359-375. doi: 10.2147/NSA.S529010. eCollection 2025.
5
Mucoadhesive PVA Film for Sustained Resveratrol Delivery: Formulation, Characterization, and Release Profile.用于白藜芦醇持续递送的粘膜粘附性聚乙烯醇薄膜:配方、表征及释放曲线
Molecules. 2025 Jun 18;30(12):2642. doi: 10.3390/molecules30122642.
6
Grape Seed Oil Microemulsion for Improved Skin Delivery of Resveratrol.用于改善白藜芦醇皮肤递送的葡萄籽油微乳液。
AAPS PharmSciTech. 2025 May 30;26(5):148. doi: 10.1208/s12249-025-03146-z.
7
NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals.NLRP3炎性小体作为阿霉素诱导的心脏毒性的治疗靶点:植物化学物质的作用
Front Pharmacol. 2025 Apr 17;16:1567312. doi: 10.3389/fphar.2025.1567312. eCollection 2025.
8
Effect of Natural Polyphenols on Breast Cancer Chemoprevention and Treatment.天然多酚对乳腺癌化学预防和治疗的作用。
Mol Nutr Food Res. 2025 Aug;69(16):e70055. doi: 10.1002/mnfr.70055. Epub 2025 Apr 7.
9
Resveratrol-A Promising Therapeutic Agent with Problematic Properties.白藜芦醇-A:一种具有问题特性的有前景的治疗剂。
Pharmaceutics. 2025 Jan 19;17(1):134. doi: 10.3390/pharmaceutics17010134.
10
Development and Characterization of Novel Combinations and Compositions of Nanostructured Lipid Carrier Formulations Loaded with Trans-Resveratrol for Pulmonary Drug Delivery.用于肺部药物递送的载有反式白藜芦醇的新型纳米结构脂质载体配方的组合与组成的开发及表征
Pharmaceutics. 2024 Dec 12;16(12):1589. doi: 10.3390/pharmaceutics16121589.
Ann N Y Acad Sci. 2011 Jan;1215:48-59. doi: 10.1111/j.1749-6632.2010.05871.x.
4
Preformulation stability of trans-resveratrol and trans-resveratrol glucoside (Piceid).反式白藜芦醇和反式白藜芦醇苷(藜芦醇苷)的制剂前稳定性。
J Agric Food Chem. 2010 Feb 10;58(3):1685-90. doi: 10.1021/jf903009f.
5
Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol.基于抗氧化剂的癌症化学预防先导物发现:白藜芦醇的案例
J Med Chem. 2009 Apr 9;52(7):1963-74. doi: 10.1021/jm8015415.
6
Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption.通过荧光光谱法和紫外可见吸收法测定的(E)-白藜芦醇的聚集状态和pKa值。
J Agric Food Chem. 2008 Sep 10;56(17):7600-5. doi: 10.1021/jf800843e. Epub 2008 Aug 14.
7
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol.水溶性和剂量对白藜芦醇药代动力学特征的影响。
Pharm Res. 2008 Nov;25(11):2593-600. doi: 10.1007/s11095-008-9677-1. Epub 2008 Jul 16.
8
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.白藜芦醇(一种潜在的癌症化学预防剂)在健康志愿者中的I期剂量递增药代动力学研究。
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52. doi: 10.1158/1055-9965.EPI-07-0022.
9
Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.白藜芦醇作为一种化学预防剂:一种对抗癌症的有前景的分子。
Curr Drug Targets. 2006 Apr;7(4):423-42. doi: 10.2174/138945006776359331.
10
High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma.大鼠血浆中反式白藜芦醇的高效液相色谱光谱分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Mar 7;832(2):177-80. doi: 10.1016/j.jchromb.2005.12.021. Epub 2006 Jan 30.